AKT1 and melanoma: 3.5. The Exposure of BRAFV600E Melanoma Cells to c-exNDI 1 Results in KIT and BCL-2 Protein Down-Regulation, Inhibition of MAPK and PI3K/AKT Signaling Pathways, and Apoptosis Induction